25 XP   0   0   10

Virios Therapeutics Llc
Buy, Hold or Sell?

Let's analyse Virios together

PenkeI guess you are interested in Virios Therapeutics Llc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Virios Therapeutics Llc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Virios Therapeutics Llc

I send you an email if I find something interesting about Virios Therapeutics Llc.

Quick analysis of Virios (30 sec.)










What can you expect buying and holding a share of Virios? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.20
Expected worth in 1 year
$0.01
How sure are you?
23.5%

+ What do you gain per year?

Total Gains per Share
$-0.18
Return On Investment
-38.1%

For what price can you sell your share?

Current Price per Share
$0.48
Expected price per share
$0.279 - $0.94
How sure are you?
50%

1. Valuation of Virios (5 min.)




Live pricePrice per Share (EOD)

$0.48

Intrinsic Value Per Share

$-2.19 - $-2.40

Total Value Per Share

$-2.00 - $-2.20

2. Growth of Virios (5 min.)




Is Virios growing?

Current yearPrevious yearGrowGrow %
How rich?$3.8m$8.5m-$3.7m-78.7%

How much money is Virios making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$3m$1.7m131.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Virios (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#787 / 1031

Most Revenue
#824 / 1031

Most Profit
#274 / 1031

Most Efficient
#264 / 1031

What can you expect buying and holding a share of Virios? (5 min.)

Welcome investor! Virios's management wants to use your money to grow the business. In return you get a share of Virios.

What can you expect buying and holding a share of Virios?

First you should know what it really means to hold a share of Virios. And how you can make/lose money.

Speculation

The Price per Share of Virios is $0.4791. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Virios.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Virios, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.20. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Virios.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-12.0%-0.07-14.1%-0.16-33.2%-0.14-28.4%-0.14-28.4%
Usd Book Value Change Per Share-0.05-10.3%-0.05-9.5%-0.09-19.4%0.012.4%0.012.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-10.3%-0.05-9.5%-0.09-19.4%0.012.4%0.012.4%
Usd Price Per Share0.58-0.81-2.33-2.50-2.50-
Price to Earnings Ratio-2.51--2.99--3.07--3.38--3.38-
Price-to-Total Gains Ratio-11.60-54.52--11.12-4.78-4.78-
Price to Book Ratio2.91-3.38-5.23-3.58-3.58-
Price-to-Total Gains Ratio-11.60-54.52--11.12-4.78-4.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4791
Number of shares2087
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.01
Usd Total Gains Per Share-0.050.01
Gains per Quarter (2087 shares)-95.3624.27
Gains per Year (2087 shares)-381.4297.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-381-39109787
20-763-7720194184
30-1144-11530291281
40-1526-15340388378
50-1907-19150485475
60-2289-22960582572
70-2670-26770680669
80-3051-30580777766
90-3433-34390874863
100-3814-38200971960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.012.01.023.5%4.012.01.023.5%4.012.01.023.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%4.012.01.023.5%4.012.01.023.5%4.012.01.023.5%

Fundamentals of Virios

About Virios Therapeutics Llc

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

Fundamental data was last updated by Penke on 2024-03-22 07:04:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Virios Therapeutics Llc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Virios earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Virios to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Virios Therapeutics Llc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y--452.4%+452.4%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Virios is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Virios to the Biotechnology industry mean.
  • -26.5% Return on Assets means that Virios generated $-0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Virios Therapeutics Llc:

  • The MRQ is -26.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -25.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.5%TTM-25.1%-1.4%
TTM-25.1%YOY-29.9%+4.8%
TTM-25.1%5Y-62.7%+37.7%
5Y-62.7%10Y-62.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.5%-12.5%-14.0%
TTM-25.1%-12.2%-12.9%
YOY-29.9%-11.2%-18.7%
5Y-62.7%-13.3%-49.4%
10Y-62.7%-14.6%-48.1%
1.1.3. Return on Equity

Shows how efficient Virios is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Virios to the Biotechnology industry mean.
  • -29.0% Return on Equity means Virios generated $-0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Virios Therapeutics Llc:

  • The MRQ is -29.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.0%TTM-27.6%-1.4%
TTM-27.6%YOY-35.9%+8.3%
TTM-27.6%5Y-21.1%-6.5%
5Y-21.1%10Y-21.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.0%-16.0%-13.0%
TTM-27.6%-15.8%-11.8%
YOY-35.9%-13.9%-22.0%
5Y-21.1%-18.2%-2.9%
10Y-21.1%-19.1%-2.0%

1.2. Operating Efficiency of Virios Therapeutics Llc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Virios is operating .

  • Measures how much profit Virios makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Virios to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Virios Therapeutics Llc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Virios is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Virios Therapeutics Llc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y-5.554-5.554
10Y-7.396-7.396

1.3. Liquidity of Virios Therapeutics Llc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Virios is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.62 means the company has $11.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Virios Therapeutics Llc:

  • The MRQ is 11.618. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.232. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.618TTM10.232+1.386
TTM10.232YOY6.530+3.702
TTM10.2325Y9.694+0.538
5Y9.69410Y9.6940.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6183.987+7.631
TTM10.2324.440+5.792
YOY6.5305.569+0.961
5Y9.6946.158+3.536
10Y9.6946.492+3.202
1.3.2. Quick Ratio

Measures if Virios is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Virios to the Biotechnology industry mean.
  • A Quick Ratio of 9.25 means the company can pay off $9.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Virios Therapeutics Llc:

  • The MRQ is 9.251. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.403. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.251TTM9.403-0.152
TTM9.403YOY5.709+3.694
TTM9.4035Y8.983+0.420
5Y8.98310Y8.9830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.2513.653+5.598
TTM9.4034.158+5.245
YOY5.7095.515+0.194
5Y8.9836.012+2.971
10Y8.9836.206+2.777

1.4. Solvency of Virios Therapeutics Llc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Virios assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Virios to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Virios assets are financed with 8.6% credit (debt) and the remaining percentage (100% - 8.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Virios Therapeutics Llc:

  • The MRQ is 0.086. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.091. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.086TTM0.091-0.005
TTM0.091YOY0.159-0.068
TTM0.0915Y2.817-2.726
5Y2.81710Y2.8170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0860.336-0.250
TTM0.0910.330-0.239
YOY0.1590.267-0.108
5Y2.8170.367+2.450
10Y2.8170.378+2.439
1.4.2. Debt to Equity Ratio

Measures if Virios is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Virios to the Biotechnology industry mean.
  • A Debt to Equity ratio of 9.4% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Virios Therapeutics Llc:

  • The MRQ is 0.094. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.100. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.100-0.006
TTM0.100YOY0.190-0.090
TTM0.1005Y0.085+0.015
5Y0.08510Y0.0850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.376-0.282
TTM0.1000.398-0.298
YOY0.1900.334-0.144
5Y0.0850.431-0.346
10Y0.0850.476-0.391

2. Market Valuation of Virios Therapeutics Llc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Virios generates.

  • Above 15 is considered overpriced but always compare Virios to the Biotechnology industry mean.
  • A PE ratio of -2.51 means the investor is paying $-2.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Virios Therapeutics Llc:

  • The EOD is -2.091. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.509. Based on the earnings, the company is expensive. -2
  • The TTM is -2.989. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.091MRQ-2.509+0.419
MRQ-2.509TTM-2.989+0.480
TTM-2.989YOY-3.067+0.078
TTM-2.9895Y-3.385+0.396
5Y-3.38510Y-3.3850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.091-2.697+0.606
MRQ-2.509-2.422-0.087
TTM-2.989-2.709-0.280
YOY-3.067-4.116+1.049
5Y-3.385-6.257+2.872
10Y-3.385-6.478+3.093
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Virios Therapeutics Llc:

  • The EOD is -1.570. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.884. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.128. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.570MRQ-1.884+0.314
MRQ-1.884TTM-4.128+2.244
TTM-4.128YOY-3.713-0.415
TTM-4.1285Y-4.586+0.457
5Y-4.58610Y-4.5860.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.570-3.344+1.774
MRQ-1.884-2.939+1.055
TTM-4.128-3.486-0.642
YOY-3.713-5.592+1.879
5Y-4.586-8.464+3.878
10Y-4.586-8.872+4.286
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Virios is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.91 means the investor is paying $2.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Virios Therapeutics Llc:

  • The EOD is 2.424. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.909. Based on the equity, the company is underpriced. +1
  • The TTM is 3.375. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.424MRQ2.909-0.485
MRQ2.909TTM3.375-0.466
TTM3.375YOY5.226-1.851
TTM3.3755Y3.576-0.201
5Y3.57610Y3.5760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4242.198+0.226
MRQ2.9092.042+0.867
TTM3.3752.121+1.254
YOY5.2262.907+2.319
5Y3.5763.682-0.106
10Y3.5764.114-0.538
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Virios Therapeutics Llc.

3.1. Institutions holding Virios Therapeutics Llc

Institutions are holding 8.116% of the shares of Virios Therapeutics Llc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc1.0847020888300
2023-12-31Renaissance Technologies Corp1.07330.00022066971926981376.5126
2023-12-31Geode Capital Management, LLC0.906017446900
2023-12-31State Street Corporation0.274305282800
2023-12-31McCollum Christoferson Group LLC0.19210.006437000370011.1111
2023-12-31Raymond James & Associates0.155803000000
2023-12-31Northern Trust Corp0.124802403500
2023-12-31XTX Topco Ltd0.11820.002922760831957.6068
2023-12-31Regions Financial Corp0.10420.00012007200
2023-12-31SIMPLEX TRADING, LLC0.0902017372-13841-44.3437
2023-12-31Morgan Stanley - Brokerage Accounts0.077901500000
2023-12-31Group One Trading, LP0.0726013982250021.7732
2023-12-31Cetera Advisors LLC0.07040.00011356000
2023-12-31Wiley Bros.-Aintree Capital, LLC0.05710.00151100000
2023-12-31Tower Research Capital LLC0.03480.00016704-2066-23.5576
2023-12-31UBS Group AG0.01350260026000
2023-12-31Cutler Group LP0.01190.0001230000
2023-12-31BlackRock Inc0.0039075500
2023-12-31Wells Fargo & Co0.0007013064.8387
2023-12-31Royal Bank of Canada0.000305600
Total 4.46670.0114860203+193916+22.5%

3.2. Funds holding Virios Therapeutics Llc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.08470.000120888300
2024-01-31Fidelity Extended Market Index0.48360.00019313100
2024-01-31Fidelity Series Total Market Index0.136402627500
2024-01-31Fidelity Nasdaq Composite Index0.11440.00012202300
2024-01-31Fidelity Total Market Index0.100801941000
2023-12-31Northern Trust Extended Eq Market Idx0.0730.00011406400
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0730.00011406400
2024-01-31Spartan Total Market Index Pool E0.060201159800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0480.0001925200
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03860.00017431140.1888
2024-01-31Spartan Extended Market Index Pool E0.01010195300
2023-12-31SSgA U.S. Extended Market Index Class I0.00680130000
2024-02-29State St US Extended Mkt Indx NL Cl C0.00680130000
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0042080000
2023-12-31NT US Market Cap Idx Fd - L0.0037071900
2023-12-31Northern Trust Wilshire 50000.0037071900
2023-12-31SSgA U.S. Total Market Index Strategy0.00190375-9-2.3438
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00160.000129910.3356
Total 2.25150.0008433596+6+0.0%

3.3. Insider Transactions

Insiders are holding 9.712% of the shares of Virios Therapeutics Llc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-21William PridgenBUY153351.3
2023-08-17Gregory Scott DuncanBUY250001.25

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Virios Therapeutics Llc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.050-0.046-8%-0.093+88%0.012-526%0.012-526%
Book Value Per Share--0.1980.250-21%0.446-56%0.445-56%0.445-56%
Current Ratio--11.61810.232+14%6.530+78%9.694+20%9.694+20%
Debt To Asset Ratio--0.0860.091-5%0.159-46%2.817-97%2.817-97%
Debt To Equity Ratio--0.0940.100-6%0.190-50%0.085+11%0.085+11%
Dividend Per Share----0%-0%-0%-0%
Eps---0.057-0.068+18%-0.159+178%-0.136+137%-0.136+137%
Free Cash Flow Per Share---0.076-0.063-17%-0.149+95%-0.111+46%-0.111+46%
Free Cash Flow To Equity Per Share--0.044-0.018+142%0.028+55%0.058-25%0.058-25%
Gross Profit Margin--1.0001.000+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---2.401--------
Intrinsic Value_10Y_min---2.195--------
Intrinsic Value_1Y_max---0.510--------
Intrinsic Value_1Y_min---0.501--------
Intrinsic Value_3Y_max---1.326--------
Intrinsic Value_3Y_min---1.270--------
Intrinsic Value_5Y_max---1.896--------
Intrinsic Value_5Y_min---1.777--------
Market Cap9226459.890-20%11073313.77515637420.119-29%44904608.325-75%48156079.428-77%48156079.428-77%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio2.424-20%2.9093.375-14%5.226-44%3.576-19%3.576-19%
Pe Ratio-2.091+17%-2.509-2.989+19%-3.067+22%-3.385+35%-3.385+35%
Price Per Share0.479-20%0.5750.812-29%2.332-75%2.501-77%2.501-77%
Price To Free Cash Flow Ratio-1.570+17%-1.884-4.128+119%-3.713+97%-4.586+143%-4.586+143%
Price To Total Gains Ratio-9.662+17%-11.59754.517-121%-11.120-4%4.781-343%4.781-343%
Quick Ratio--9.2519.403-2%5.709+62%8.983+3%8.983+3%
Return On Assets---0.265-0.251-5%-0.299+13%-0.627+137%-0.627+137%
Return On Equity---0.290-0.276-5%-0.359+24%-0.211-27%-0.211-27%
Total Gains Per Share---0.050-0.046-8%-0.093+88%0.012-526%0.012-526%
Usd Book Value--3806893.0004808017.000-21%8591588.750-56%8575767.765-56%8575767.765-56%
Usd Book Value Change Per Share---0.050-0.046-8%-0.093+88%0.012-526%0.012-526%
Usd Book Value Per Share--0.1980.250-21%0.446-56%0.445-56%0.445-56%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.057-0.068+18%-0.159+178%-0.136+137%-0.136+137%
Usd Free Cash Flow---1469171.000-1217622.250-17%-2866949.250+95%-2140869.000+46%-2140869.000+46%
Usd Free Cash Flow Per Share---0.076-0.063-17%-0.149+95%-0.111+46%-0.111+46%
Usd Free Cash Flow To Equity Per Share--0.044-0.018+142%0.028+55%0.058-25%0.058-25%
Usd Market Cap9226459.890-20%11073313.77515637420.119-29%44904608.325-75%48156079.428-77%48156079.428-77%
Usd Price Per Share0.479-20%0.5750.812-29%2.332-75%2.501-77%2.501-77%
Usd Profit---1103173.000-1313898.000+19%-3045089.750+176%-2610659.000+137%-2610659.000+137%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.050-0.046-8%-0.093+88%0.012-526%0.012-526%
 EOD+3 -5MRQTTM+11 -19YOY+21 -95Y+13 -1710Y+13 -17

4.2. Fundamental Score

Let's check the fundamental score of Virios Therapeutics Llc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.091
Price to Book Ratio (EOD)Between0-12.424
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.251
Current Ratio (MRQ)Greater than111.618
Debt to Asset Ratio (MRQ)Less than10.086
Debt to Equity Ratio (MRQ)Less than10.094
Return on Equity (MRQ)Greater than0.15-0.290
Return on Assets (MRQ)Greater than0.05-0.265
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Virios Therapeutics Llc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.437
Ma 20Greater thanMa 500.371
Ma 50Greater thanMa 1000.403
Ma 100Greater thanMa 2000.531
OpenGreater thanClose0.490
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,165
Total Liabilities359
Total Stockholder Equity3,807
 As reported
Total Liabilities 359
Total Stockholder Equity+ 3,807
Total Assets = 4,165

Assets

Total Assets4,165
Total Current Assets4,165
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 3,317
Other Current Assets 848
Total Current Assets  (as reported)4,165
Total Current Assets  (calculated)4,165
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities359
Long-term Liabilities0
Total Stockholder Equity3,807
Total Current Liabilities
Accounts payable 112
Other Current Liabilities 247
Total Current Liabilities  (as reported)359
Total Current Liabilities  (calculated)359
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -61,469
Other Stockholders Equity 65,274
Total Stockholder Equity (as reported)3,807
Total Stockholder Equity (calculated)3,807
+/-0
Other
Capital Stock2
Cash and Short Term Investments 3,317
Common Stock Shares Outstanding 19,258
Liabilities and Stockholders Equity 4,165
Net Debt -3,317
Net Invested Capital 3,807
Net Working Capital 3,807



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
> Total Assets 
0
0
316
0
1,273
785
31,473
28,275
23,765
20,107
15,777
12,550
9,040
10,858
8,370
6,521
5,212
5,249
4,165
4,1655,2495,2126,5218,37010,8589,04012,55015,77720,10723,76528,27531,4737851,273031600
   > Total Current Assets 
0
0
316
0
1,213
560
31,473
24,586
23,765
20,107
15,777
12,550
9,040
10,858
8,370
5,333
4,590
5,249
4,165
4,1655,2494,5905,3338,37010,8589,04012,55015,77720,10723,76524,58631,4735601,213031600
       Cash And Cash Equivalents 
0
0
309
0
1,048
499
29,795
24,586
21,835
19,186
14,008
11,352
7,695
9,788
7,031
5,333
4,590
4,786
3,317
3,3174,7864,5905,3337,0319,7887,69511,35214,00819,18621,83524,58629,7954991,048030900
       Net Receivables 
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000100
       Other Current Assets 
0
0
6
0
164
61
1,677
3,689
1
21
1
34
25
14
7
54
32
19
848
848193254714253412113,6891,677611640600
   > Long-term Assets 
0
0
0
0
60
225
0
3,689
0
0
0
0
0
0
0
1,188
622
0
0
006221,18800000003,6890225600000
       Other Assets 
0
0
0
0
60
225
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000225600000
> Total Liabilities 
0
0
5,258
0
7,336
5,935
1,532
1,167
906
1,227
1,276
1,877
1,898
1,633
1,043
549
520
487
359
3594875205491,0431,6331,8981,8771,2761,2279061,1671,5325,9357,33605,25800
   > Total Current Liabilities 
0
0
1,621
0
1,850
1,784
1,532
1,167
906
1,227
1,276
1,877
1,898
1,633
1,043
549
520
487
359
3594875205491,0431,6331,8981,8771,2761,2279061,1671,5321,7841,85001,62100
       Accounts payable 
0
0
35
0
198
199
369
615
263
483
354
331
666
679
573
135
214
205
112
11220521413557367966633135448326361536919919803500
       Other Current Liabilities 
0
0
1,585
0
1,652
1,585
1,163
508
644
743
922
1,547
1,232
954
470
414
306
282
247
2472823064144709541,2321,5479227436445081,1631,5851,65201,58500
   > Long-term Liabilities 
0
0
3,638
0
5,486
4,151
0
0
0
0
354
331
666
679
573
135
0
0
0
00013557367966633135400004,1515,48603,63800
       Deferred Long Term Liability 
0
0
0
0
60
225
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000225600000
> Total Stockholder Equity
0
0
-4,943
0
-6,064
-5,150
29,941
27,107
22,859
18,880
14,501
10,673
7,142
9,225
7,326
5,971
4,692
4,762
3,807
3,8074,7624,6925,9717,3269,2257,14210,67314,50118,88022,85927,10729,941-5,150-6,0640-4,94300
   Common Stock
0
0
12,601
0
12,601
16,239
1
1
1
1
1
1
1
2
2
2
2
2
2
222222111111116,23912,601012,60100
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
75
0
0
0
57,905
58,128
58,162
58,294
58,426
58,558
58,694
63,352
63,498
63,660
63,821
65,126
65,274
65,27465,12663,82163,66063,49863,35258,69458,55858,42658,29458,16258,12857,9050007500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-5,447
Operating Income-5,447-5,447
 
Operating Expense (+$)
Research Development1,728
Selling General Administrative3,719
Selling And Marketing Expenses0
Operating Expense5,4475,447
 
Net Interest Income (+$)
Interest Income151
Interest Expense-0
Other Finance Cost-10
Net Interest Income161
 
Pretax Income (+$)
Operating Income-5,447
Net Interest Income161
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,296-5,598
EBIT - interestExpense = 0
-5,296
-5,296
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-5,296
Earnings Before Interest and Taxes (EBITDA)-5,447
 
After tax Income (+$)
Income Before Tax-5,296
Tax Provision-0
Net Income From Continuing Ops-6,237-5,296
Net Income-5,296
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,447
Total Other Income/Expenses Net151-161
 

Technical Analysis of Virios
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Virios. The general trend of Virios is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Virios's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Virios Therapeutics Llc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.517 < 0.907 < 0.94.

The bearish price targets are: 0.46 > 0.304 > 0.279.

Tweet this
Virios Therapeutics Llc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Virios Therapeutics Llc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Virios Therapeutics Llc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Virios Therapeutics Llc. The current macd is 0.01516486.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Virios price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Virios. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Virios price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Virios Therapeutics Llc Daily Moving Average Convergence/Divergence (MACD) ChartVirios Therapeutics Llc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Virios Therapeutics Llc. The current adx is 25.69.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Virios shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Virios Therapeutics Llc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Virios Therapeutics Llc. The current sar is 0.3602.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Virios Therapeutics Llc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Virios Therapeutics Llc. The current rsi is 61.44. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Virios Therapeutics Llc Daily Relative Strength Index (RSI) ChartVirios Therapeutics Llc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Virios Therapeutics Llc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Virios price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Virios Therapeutics Llc Daily Stochastic Oscillator ChartVirios Therapeutics Llc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Virios Therapeutics Llc. The current cci is 139.68.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Virios Therapeutics Llc Daily Commodity Channel Index (CCI) ChartVirios Therapeutics Llc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Virios Therapeutics Llc. The current cmo is 34.19.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Virios Therapeutics Llc Daily Chande Momentum Oscillator (CMO) ChartVirios Therapeutics Llc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Virios Therapeutics Llc. The current willr is -44.18536009.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Virios is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Virios Therapeutics Llc Daily Williams %R ChartVirios Therapeutics Llc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Virios Therapeutics Llc.

Virios Therapeutics Llc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Virios Therapeutics Llc. The current atr is 0.07967963.

Virios Therapeutics Llc Daily Average True Range (ATR) ChartVirios Therapeutics Llc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Virios Therapeutics Llc. The current obv is 113,884,180.

Virios Therapeutics Llc Daily On-Balance Volume (OBV) ChartVirios Therapeutics Llc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Virios Therapeutics Llc. The current mfi is 85.61.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Virios Therapeutics Llc Daily Money Flow Index (MFI) ChartVirios Therapeutics Llc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Virios Therapeutics Llc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Virios Therapeutics Llc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Virios Therapeutics Llc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.437
Ma 20Greater thanMa 500.371
Ma 50Greater thanMa 1000.403
Ma 100Greater thanMa 2000.531
OpenGreater thanClose0.490
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Virios with someone you think should read this too:
  • Are you bullish or bearish on Virios? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Virios? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Virios Therapeutics Llc

I send you an email if I find something interesting about Virios Therapeutics Llc.


Comments

How you think about this?

Leave a comment

Stay informed about Virios Therapeutics Llc.

Receive notifications about Virios Therapeutics Llc in your mailbox!